SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19777258
Source:
http://linkedlifedata.com/resource/pubmed/id/19777258
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007131
,
umls-concept:C0205179
,
umls-concept:C0205210
,
umls-concept:C0242982
,
umls-concept:C0430054
,
umls-concept:C0596611
,
umls-concept:C1274040
,
umls-concept:C1516213
,
umls-concept:C1705053
pubmed:issue
4
pubmed:dateCreated
2010-2-19
pubmed:abstractText
To evaluate the relationship between the epidermal growth factor receptor (EGFR) mutation status and the effectiveness of gefitinib monotherapy or chemotherapy in patients with advanced non-small cell lung cancer (NSCLC).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7902060
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/gefitinib
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1432-1335
pubmed:author
pubmed-author:HidaToyoakiT
,
pubmed-author:HorioYoshitsuguY
,
pubmed-author:MatsuoKeitaroK
,
pubmed-author:MitsudomiTetsuyaT
,
pubmed-author:OgawaShizuS
,
pubmed-author:ParkJangchulJ
,
pubmed-author:ParkJi YoungJY
,
pubmed-author:ShimizuJunichiJ
,
pubmed-author:YatabeYasushiY
,
pubmed-author:YoshidaKimihideK
pubmed:issnType
Electronic
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
527-35
pubmed:meshHeading
pubmed-meshheading:19777258-Aged
,
pubmed-meshheading:19777258-Carcinoma, Non-Small-Cell Lung
,
pubmed-meshheading:19777258-Cohort Studies
,
pubmed-meshheading:19777258-Disease-Free Survival
,
pubmed-meshheading:19777258-Exons
,
pubmed-meshheading:19777258-Female
,
pubmed-meshheading:19777258-Genetic Testing
,
pubmed-meshheading:19777258-Humans
,
pubmed-meshheading:19777258-Lung Neoplasms
,
pubmed-meshheading:19777258-Male
,
pubmed-meshheading:19777258-Middle Aged
,
pubmed-meshheading:19777258-Mutation
,
pubmed-meshheading:19777258-Neoplasm Staging
,
pubmed-meshheading:19777258-Protein Kinase Inhibitors
,
pubmed-meshheading:19777258-Quinazolines
,
pubmed-meshheading:19777258-Receptor, Epidermal Growth Factor
,
pubmed-meshheading:19777258-Retrospective Studies
pubmed:year
2010
pubmed:articleTitle
Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.
pubmed:affiliation
Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. 105197@aichi-cc.jp
pubmed:publicationType
Journal Article